164 related articles for article (PubMed ID: 33545795)
1. Analysis of the correlation between plasma coagulation factor VII, PAI-1, and uric acid with insulin resistance and macrovascular complications in elderly patients with type 2 diabetes.
Li L; Shi Z; Ma L; Lu Y
Ann Palliat Med; 2021 Jan; 10(1):664-671. PubMed ID: 33545795
[TBL] [Abstract][Full Text] [Related]
2. Albuminuria is directly associated with increased plasma PAI-1 and factor VII levels in NIDDM patients.
Hirano T; Kashiwazaki K; Moritomo Y; Nagano S; Adachi M
Diabetes Res Clin Pract; 1997 Apr; 36(1):11-8. PubMed ID: 9187410
[TBL] [Abstract][Full Text] [Related]
3. Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.
De Pergola G; De Mitrio V; Sciaraffia M; Pannacciulli N; Minenna A; Giorgino F; Petronelli M; Laudadio E; Giorgino R
Metabolism; 1997 Nov; 46(11):1287-93. PubMed ID: 9361687
[TBL] [Abstract][Full Text] [Related]
4. Weight change and blood coagulability and fibrinolysis in healthy obese women.
Rissanen P; Vahtera E; Krusius T; Uusitupa M; Rissanen A
Int J Obes Relat Metab Disord; 2001 Feb; 25(2):212-8. PubMed ID: 11410822
[TBL] [Abstract][Full Text] [Related]
5. The evaluation of the role of BMI and insulin resistance on inflammatory markers, PAI-1 levels and arterial stiffness in newly diagnosed type 2 diabetes mellitus patients.
Koca N; Ayar K; Bal Ö; Ersoy C
Minerva Endocrinol (Torino); 2021 Mar; 46(1):116-123. PubMed ID: 33779113
[TBL] [Abstract][Full Text] [Related]
6. Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients.
Tomura S; Nakamura Y; Doi M; Ando R; Ida T; Chida Y; Ootsuka S; Shinoda T; Yanagi H; Tsuchiya S; Marumo F
Am J Kidney Dis; 1996 Jun; 27(6):848-54. PubMed ID: 8651250
[TBL] [Abstract][Full Text] [Related]
7. Factor VII gene polymorphisms, factor VII:C levels and features of insulin resistance in non-insulin-dependent diabetes mellitus.
Heywood DM; Mansfield MW; Grant PJ
Thromb Haemost; 1996 Mar; 75(3):401-6. PubMed ID: 8701397
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD4+CD25+Foxp3+ Regulatory T Cells, Interleukin 10 and Transforming Growth Factor β in Newly Diagnosed Type 2 Diabetic Patients.
Yuan N; Zhang HF; Wei Q; Wang P; Guo WY
Exp Clin Endocrinol Diabetes; 2018 Feb; 126(2):96-101. PubMed ID: 28954308
[TBL] [Abstract][Full Text] [Related]
9. Association of plasminogen activator inhibitor-1 with insulin resistance in Japan where obesity is rare.
Nakamura T; Adachi H; Hirai Y; Satoh A; Ohuchida M; Imaizumi T
Metabolism; 2003 Feb; 52(2):226-9. PubMed ID: 12601637
[TBL] [Abstract][Full Text] [Related]
10. PAI-1 gene 4G/5G polymorphism, cytokine levels and their relations with metabolic parameters in obese children.
Kinik ST; Ozbek N; Yuce M; Yazici AC; Verdi H; Ataç FB
Thromb Haemost; 2008 Feb; 99(2):352-6. PubMed ID: 18278185
[TBL] [Abstract][Full Text] [Related]
11. Relationship Between Four Non-Insulin-Based Indexes of Insulin Resistance and Serum Uric Acid in Patients with Type 2 Diabetes: A Cross-Sectional Study.
Han R; Zhang Y; Jiang X
Diabetes Metab Syndr Obes; 2022; 15():1461-1471. PubMed ID: 35591906
[TBL] [Abstract][Full Text] [Related]
12. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.
Kruszynska YT; Yu JG; Olefsky JM; Sobel BE
Diabetes; 2000 Apr; 49(4):633-9. PubMed ID: 10871202
[TBL] [Abstract][Full Text] [Related]
13. Relationship between changes in plasma leptin concentrations and plasminogen activator inhibitor-1 in obese prepubertal children after nine months of treatment.
Valle Jiménez M; Martos R; Morales RM; Valle R; Cañete MD; Urbano MM; Bermudo F; Cañete R
Ann Nutr Metab; 2013; 63(3):216-22. PubMed ID: 24135306
[TBL] [Abstract][Full Text] [Related]
14. Chemerin and apelin are positively correlated with inflammation in obese type 2 diabetic patients.
Yu S; Zhang Y; Li MZ; Xu H; Wang Q; Song J; Lin P; Zhang L; Liu Q; Huang QX; Wang K; Hou WK
Chin Med J (Engl); 2012 Oct; 125(19):3440-4. PubMed ID: 23044303
[TBL] [Abstract][Full Text] [Related]
15. Association Between Triglyceride-Glucose Index and Serum Uric Acid Levels: A Biochemical Study on Anthropometry in Non-Obese Type 2 Diabetes Mellitus Patients.
Luo Y; Hao J; He X; Wang C; Zhao H; Zhang Z; Yang L; Ren L
Diabetes Metab Syndr Obes; 2022; 15():3447-3458. PubMed ID: 36353666
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory and prothrombotic parameters in normotensive non-diabetic obese women: effect of weight loss obtained by gastric banding.
Cugno M; Castelli R; Mari D; Mozzi E; Zappa MA; Boscolo-Anzoletti M; Roviaro G; Mannucci PM
Intern Emerg Med; 2012 Jun; 7(3):237-42. PubMed ID: 21249470
[TBL] [Abstract][Full Text] [Related]
17. Different metabolic correlations of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 in non-obese type 2 diabetic patients.
Kitagawa N; Yano Y; Gabazza EC; Bruno NE; Araki R; Matsumoto K; Katsuki A; Hori Y; Nakatani K; Taguchi O; Sumida Y; Suzuki K; Adachi Y
Diabetes Res Clin Pract; 2006 Aug; 73(2):150-7. PubMed ID: 16458385
[TBL] [Abstract][Full Text] [Related]
18. Association of plasminogen activator inhibitor-1 and fibroblastic growth factor 21 in 3 groups of type 2 diabetes: Without overweight/obesity, free of insulin resistance, and without hepatosteatosis.
Takebe N; Hasegawa Y; Matsushita Y; Chiba H; Onodera K; Kinno H; Oda T; Nagasawa K; Segawa T; Takahashi Y; Okada K; Ishigaki Y
Medicine (Baltimore); 2023 Sep; 102(35):e34797. PubMed ID: 37657012
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor-1 in nonobese subjects with non-insulin-dependent diabetes mellitus.
Ito Y; Okeda T; Sato Y; Ito M; Sakata T
Proc Soc Exp Biol Med; 1996 Mar; 211(3):287-91. PubMed ID: 8633110
[TBL] [Abstract][Full Text] [Related]
20. Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in patients with type 2 diabetes mellitus.
Zhou X; Xu J
J Diabetes Investig; 2024 Jan; 15(1):113-120. PubMed ID: 37737515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
